Senseonics Announces Transfer to Nasdaq Stock Exchange

Core Points - Senseonics Holdings, Inc. will transfer its common stock listing from NYSE American to Nasdaq Global Select Market, effective after market close on November 14, 2025, with trading on Nasdaq starting November 17, 2025 [1] - The company specializes in long-term, implantable continuous glucose monitoring systems for diabetes management, with products like Eversense® 365 and Eversense® E3 [2] Company Overview - Senseonics is focused on developing and manufacturing glucose monitoring products aimed at improving the lives of individuals in the diabetes community [2] - The company's CGM systems feature a small sensor that is implanted under the skin and communicates with a smart transmitter, sending glucose data to a mobile app every 5 minutes [2]